A gene expression signature classifying telomerase and ALT immortalisation reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT

[1]  X. Hong,et al.  siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells , 2008, Journal of experimental & clinical cancer research : CR.

[2]  J. Yu,et al.  Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. , 2008, Biochemical and biophysical research communications.

[3]  N. Zaffaroni,et al.  High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma , 2008, British Journal of Cancer.

[4]  M. Suvà,et al.  EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. , 2008, Cancer research.

[5]  Tzu-chien V. Wang,et al.  Heterogeneous nuclear ribonucleoprotein A3 binds single-stranded telomeric DNA and inhibits telomerase extension in vitro. , 2008, Biochimica et biophysica acta.

[6]  W. Keith,et al.  Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. , 2008, Biochimie.

[7]  N. Socci,et al.  Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. , 2007, The Journal of clinical investigation.

[8]  R. Reddel,et al.  Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres* , 2007, Journal of Biological Chemistry.

[9]  A. Cometa,et al.  Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms , 2010 .

[10]  B. Alman,et al.  Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. , 2007, Cancer research.

[11]  R. Reddel,et al.  Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference , 2007, Oncogene.

[12]  O. Delattre,et al.  Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.

[13]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[14]  L. Mariani,et al.  Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. , 2006, Cancer research.

[15]  R. Reddel,et al.  Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. , 2006, Cancer research.

[16]  Baojin Fu,et al.  Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation , 2006, Stem cells.

[17]  Nedime Serakinci,et al.  Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell. , 2006, Regenerative medicine.

[18]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[19]  R. Glasspool,et al.  Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. , 2005, Cancer research.

[20]  A. Patchefsky,et al.  Multiple Mechanisms of Telomere Maintenance Exist in Liposarcomas , 2005, Clinical Cancer Research.

[21]  J. Cigudosa,et al.  Spontaneous human adult stem cell transformation. , 2005, Cancer research.

[22]  D. Huso,et al.  Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. , 2005, Cytotherapy.

[23]  Dihua Yu,et al.  A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  M. Ladanyi,et al.  Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas , 2004, Genes, chromosomes & cancer.

[25]  T. Jensen,et al.  Adult human mesenchymal stem cell as a target for neoplastic transformation , 2004, Oncogene.

[26]  C. Waller,et al.  Lack of telomerase activity in human mesenchymal stem cells , 2003, Leukemia.

[27]  M. Ladanyi,et al.  Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. , 2003, Cancer research.

[28]  J. Royds,et al.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003, The Lancet.

[29]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[30]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[31]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[32]  J. Shay,et al.  Telomerase activity in human renal cell carcinoma. , 1996, Oncogene.